Food–Medication Interaction Detector (CYP450)
Flags interactions between foods/nutrients and antidiabetics, statins, anticoagulants, and antihypertensives.
Choose a diet plan, ebook, or workout plan to continue shopping.
| Parameter | Value | Parameter | Value |
|---|---|---|---|
|
Dosage
|
20 mg |
Strength
|
20 mg |
|
Pack Size
|
05909990903382 ¦ Rp ¦ 69412 7 kaps. w blistrach 05909990903399 ¦ Rp ¦ 69413 14 kaps. w blistrach 05909990903405 ¦ Rp ¦ 69414 15 kaps. w blistrach 05909990903436 ¦ Rp ¦ 69415 28 kaps. w blistrach 05909990903443 ¦ Rp ¦ 69416 30 kaps. w blistrach 05909990903 |
Form
|
Kapsułki dojelitowe, twarde |
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Rejestry E-zdrowia
Ludzki
doustna
18664
Bezterminowe
Laboratorios Liconsa, S.A. Novartis Farmacéutica S.A Novartis Pharma GmbH Sandoz A/S
Hiszpania Hiszpania Niemcy Dania
art. 15 ust. 1 pkt 2
Search for medications, check dosage, side effects and contraindications.
Explore dedicated Diets Premium ecosystem applications matched to this topic or cycle through more clinical tools.
Flags interactions between foods/nutrients and antidiabetics, statins, anticoagulants, and antihypertensives.
Detects absorption blockers between supplements, drugs, and morning coffee, aligning them with blood tests into a daily schedule.
Models blood glucose and insulin responses for any recipe, food, or diet day, factoring in fiber and lipid buffering.
Estimates body fat percentage and lean muscle mass from neck, waist, and hip circumferences.